These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 9329774)

  • 1. Recent advances in the pharmacological control of energy balance and body weight.
    Atkinson RL
    Ann N Y Acad Sci; 1997 Sep; 827():449-60. PubMed ID: 9329774
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological treatment of obesity: therapeutic strategies.
    Kordik CP; Reitz AB
    J Med Chem; 1999 Jan; 42(2):181-201. PubMed ID: 9925722
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current pharmacotherapy of obesity].
    Krysiak R; Okopień B; Madej A; Belowski D; Herman ZS
    Pol Arch Med Wewn; 2000 Dec; 104(6):879-87. PubMed ID: 11424668
    [No Abstract]   [Full Text] [Related]  

  • 4. Update on the pharmacotherapy of obesity.
    Cerulli J; Lomaestro BM; Malone M
    Ann Pharmacother; 1998 Jan; 32(1):88-102. PubMed ID: 9475827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of drugs in the treatment of obesity.
    Atkinson RL
    Annu Rev Nutr; 1997; 17():383-403. PubMed ID: 9240933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy for the obese patient.
    Dickerson LM; Carek PJ
    Prim Care; 2009 Jun; 36(2):407-15. PubMed ID: 19501251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on the pharmacotherapy of obesity. 1998.
    Cerulli J; Lomaestro BM; Malone M
    Ann Pharmacother; 2007 Sep; 41(9):1505-17. PubMed ID: 17698892
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug-clinics. The hue and cry over central appetite suppressants!].
    Scheen AJ
    Rev Med Liege; 1997 Sep; 52(9):613-5. PubMed ID: 9441348
    [No Abstract]   [Full Text] [Related]  

  • 9. Adrenergic control of lipolysis and metabolic responses in obesity.
    Zahorska-Markiewicz B; Kucio C; Piskorska D
    Horm Metab Res; 1986 Oct; 18(10):693-7. PubMed ID: 2877928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of caffeine on energy balance.
    Harpaz E; Tamir S; Weinstein A; Weinstein Y
    J Basic Clin Physiol Pharmacol; 2017 Jan; 28(1):1-10. PubMed ID: 27824614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What do pharmacological approaches to obesity management offer? Linking pharmacological mechanisms of obesity management agents to clinical practice.
    Astrup A; Lundsgaard C
    Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 2():29-34. PubMed ID: 9792479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermogenic ingredients and body weight regulation.
    Hursel R; Westerterp-Plantenga MS
    Int J Obes (Lond); 2010 Apr; 34(4):659-69. PubMed ID: 20142827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethanolic extracts of Brassica campestris spp. rapa roots prevent high-fat diet-induced obesity via beta(3)-adrenergic regulation of white adipocyte lipolytic activity.
    An S; Han JI; Kim MJ; Park JS; Han JM; Baek NI; Chung HG; Choi MS; Lee KT; Jeong TS
    J Med Food; 2010 Apr; 13(2):406-14. PubMed ID: 20132043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotrophic factor control of satiety and body weight.
    Xu B; Xie X
    Nat Rev Neurosci; 2016 May; 17(5):282-92. PubMed ID: 27052383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical interaction: leptin and ghrelin.
    Williams J; Mobarhan S
    Nutr Rev; 2003 Nov; 61(11):391-3. PubMed ID: 14677575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pindolol and milnacipran versus milnacipran and placebo on plasma prolactin and adrenocorticotrophic hormone in depressed subjects.
    Isaac MB; Isaac MT
    Hum Psychopharmacol; 2003 Oct; 18(7):569-74. PubMed ID: 14533141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Energy expenditure and substrate oxidation rates of obese rats during a 12-day treatment with dexfenfluramine.
    Boschmann M; Aust L; Frenz U; Noack R
    Ann Nutr Metab; 1996; 40(1):10-23. PubMed ID: 8722302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PF-05231023, a long-acting FGF21 analogue, decreases body weight by reduction of food intake in non-human primates.
    Thompson WC; Zhou Y; Talukdar S; Musante CJ
    J Pharmacokinet Pharmacodyn; 2016 Aug; 43(4):411-25. PubMed ID: 27405817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug treatment of obesity].
    Yoshida T
    Nihon Rinsho; 1995 Jun; 53 Suppl():481-6. PubMed ID: 7563798
    [No Abstract]   [Full Text] [Related]  

  • 20. Serotonergic drugs : effects on appetite expression and use for the treatment of obesity.
    Halford JC; Harrold JA; Boyland EJ; Lawton CL; Blundell JE
    Drugs; 2007; 67(1):27-55. PubMed ID: 17209663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.